TrademarkOpen
Search / United States / 98263049

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

EBRUMA

Allowed — statement of use stage
Third Extension - Granted
Used for: Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular…
Show more

Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 9 Nov 2023
    Application filed
    New Application Entered
  2. 6 Jun 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 6 Jun 2024
    Approved for publication
    Approved For Pub - Principal Register
  4. 9 Jul 2024
    Published for opposition
    Published For Opposition
  5. 3 Sep 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 27 Feb 2025
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 30 Aug 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  8. 2 Mar 2026
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 23 events
2026-03-03Notice Of Approval Of Extension Request E-Mailed
2026-03-02Sou Teas Extension Received
2026-03-02Sou Extension 3 Filed
2026-03-02Sou Extension 3 Granted
2025-09-15Notice Of Approval Of Extension Request E-Mailed
2025-08-30Sou Teas Extension Received
2025-08-30Sou Extension 2 Filed
2025-08-30Sou Extension 2 Granted
2025-06-30Teas Change Of Owner Address Received
2025-06-30Applicant/Correspondence Changes (Non-Responsive) Entered
2025-06-30Teas Change Of Correspondence Received
2025-02-27Sou Extension 1 Granted
2025-02-27Notice Of Approval Of Extension Request E-Mailed
2025-02-26Sou Teas Extension Received
2025-02-26Sou Extension 1 Filed
2024-09-03Noa Mailed - Sou Required From Applicant
2024-07-09Published For Opposition
2024-07-09Official Gazette Publication Confirmation E-Mailed
2024-06-19Notification Of Notice Of Publication E-Mailed
2024-06-06Assigned To Examiner
2024-06-06Approved For Pub - Principal Register
2024-01-28New Application Office Supplied Data Entered
2023-11-09New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 4 Mar 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.